These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12673081)

  • 1. Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis.
    Chosidow O; Maurette C; Dupuy P
    Dermatology; 2003; 206(3):233-40. PubMed ID: 12673081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis.
    Dupuy P; Maurette C; Amoric JC; Chosidow O;
    Br J Dermatol; 2001 May; 144(5):1033-7. PubMed ID: 11359393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
    Seckin D; Gurbuz O; Akin O
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
    Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
    J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis:a randomized, double-blind, comparative study.
    Diehl C; Ferrari A
    J Drugs Dermatol; 2013 Mar; 12(3):312-5. PubMed ID: 23545914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of a new ciclopiroxolamine/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment.
    Lorette G; Ermosilla V
    Eur J Dermatol; 2006; 16(5):558-64. PubMed ID: 17101479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: an open-label trial utilizing clinical evaluation and erythema-directed digital photography.
    Dall' Oglio F; Tedeschi A; Fusto CM; Lacarrubba F; Dinotta F; Micali G
    G Ital Dermatol Venereol; 2017 Oct; 152(5):436-440. PubMed ID: 28121079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
    Elewski B
    Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis: A multicenter, double-blind, randomized controlled study.
    Joly P; Tejedor I; Tetart F; Cailleux HC; Barrel A; De Preville PA; Mion-Mouton N; Gabison G; Baricault S; Tordeur CG; Dore MX; Rossi B; Bourseau-Quetier C; Chamaillard M; Ly S; Chosidow O; Richard-Lallemand MA; Rzeznik JC; Amici JM; Lair G; Bechu S; Benichou J; Thill C; Beylot-Barry M
    J Am Acad Dermatol; 2021 May; 84(5):1278-1284. PubMed ID: 33010323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium gluconate 8% vs ketoconazole 2% in the treatment of seborrhoeic dermatitis: a multicentre, randomized study.
    Dreno B; Chosidow O; Revuz J; Moyse D;
    Br J Dermatol; 2003 Jun; 148(6):1230-6. PubMed ID: 12828753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial.
    Elewski B; Ling MR; Phillips TJ
    J Drugs Dermatol; 2006; 5(7):646-50. PubMed ID: 16865870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciclopiroxolamine cream for treating seborrheic dermatitis: a double-blind parallel group comparison.
    Unholzer A; Varigos G; Nicholls D; Schinzel S; Nietsch KH; Ulbricht H; Korting HC
    Infection; 2002 Dec; 30(6):373-6. PubMed ID: 12478328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind placebo-controlled study of ketoconazole + desonide gel combination in the treatment of facial seborrheic dermatitis.
    Piérard-Franchimont C; Piérard GE
    Dermatology; 2002; 204(4):344-7. PubMed ID: 12077544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketoconazole gel 2% in the treatment of moderate to severe seborrheic dermatitis.
    Swinyer LJ; Decroix J; Langner A; Quiring JN; Blockhuys S
    Cutis; 2007 Jun; 79(6):475-82. PubMed ID: 17713152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review.
    Gupta AK; Versteeg SG
    Am J Clin Dermatol; 2017 Apr; 18(2):193-213. PubMed ID: 27804089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is topical metronidazole effective in seborrheic dermatitis? A double-blind study.
    Koca R; Altinyazar HC; Eştürk E
    Int J Dermatol; 2003 Aug; 42(8):632-5. PubMed ID: 12890109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different regimens of pimecrolimus 1% cream in the treatment of facial seborrheic dermatitis.
    Zhao J; Sun W; Zhang C; Wu J; Le Y; Huang C; Liu Y; Xiang L
    J Cosmet Dermatol; 2018 Feb; 17(1):90-94. PubMed ID: 28589618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of seborrheic eczema with an antifungal agent with an antiphlogistic effect].
    Hänel H; Smith-Kurtz E; Pastowsky S
    Mycoses; 1991; 34 Suppl 1():91-3. PubMed ID: 1840158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciclopirox gel for seborrheic dermatitis of the scalp.
    Aly R; Katz HI; Kempers SE; Lookingbill DP; Lowe N; Menter A; Morman M; Savin RC; Wortzman M
    Int J Dermatol; 2003 Sep; 42 Suppl 1():19-22. PubMed ID: 12895183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lithium gluconate 8% in the treatment of seborrheic dermatitis].
    Dréno B; Blouin E; Moyse D
    Ann Dermatol Venereol; 2007 Apr; 134(4 Pt 1):347-51. PubMed ID: 17483754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.